Organoids were cultured from healthy donor iPSC sources and differentiated using the human iPSC-derived Cerebral Organoid ...
Zacks.com on MSN13h
Is Now the Right Time to Hold on to Charles River Stock?CRL's solid prospects in the DSA segment and strategic partnerships present a promising opportunity for investors.
Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, announces a change in its Board of Directors with the departure ...
Four University of Cape Town (UCT) researchers are among 30 outstanding scientists recognised in the Fondation L’Oréal-UNESCO ...
A study done to strengthen healthcare delivery in Africa was Friday launched on the sideline of the 38th African Union Summit in Addis Ababa, Ethiopia. Dubbed Leveraging Research Prioritisation and ...
LATS1/2-inactivation and consequent nuclear YAP/TAZ hyperactivation in the mammary epithelium drives the development of a pro ...
Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, announces a change in its Board of Directors with the departure of Ms. Anat Loewenstein and Ms. Nathalie ...
Development of Prediction Model for Brain Amyloid-Beta Accumulation for Early Screening of Alzheimer's Disease MACHINE LEARNING MODEL USING ...
The Tokyo-based biotech firm expects RV-001 to be able to alter light sensitivity for patients with limited or no vision regardless of genotype.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback